Hans Biomed expands BOUNS breast implant supply to South Korean hospitals

Verifying
  • Hans Biomed expanded BOUNS supply to four South Korean tertiary general hospitals.
  • The company plans to add 25 more tertiary general hospitals by year-end.
  • BOUNS launched in South Korea in April as Bellagel's successor.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.